Literature DB >> 30119213

Xuebijing injection induces anti-inflammatory-like effects and downregulates the expression of TLR4 and NF-κB in lung injury caused by dichlorvos poisoning.

Fei He1, Jun Wang1, Yao Liu1, Xiaojing Wang1, Nan Cai1, Chao Wu2, Qingling Gao3.   

Abstract

BACKGROUND: The mechanism in lung injury caused by acute organophosphate pesticide poisoning (AOPP) and an effective treatment remains unclear. We aim to clarify how the inflammatory lung injury caused by AOPP might be modulated by Xuebijing (XBJ) injection.
METHODS: AOPP-induced lung injury model was induced by dichlorvos (DDVP) subcutaneous administration in rats and XBJ injection was administered by intraperitoneal injection after DDVP challenge. The effects of XBJ injection were assessed by lung histopathological analysis and lung injury scores, lung wet-to-dry weight ratios (WDR) and oxygenation, differential immune cell count in bronchoalveolar lavage fluid (BALF), IL-6 and TNF-α levels in blood, the levels of TLR4 and NF-κB proteins in lung tissue and blood acetylcholinesterase (AChE) activity.
RESULTS: DDVP administration resulted in damage of lung histopathology and lower PaO2/FiO2 ratios (P < 0.05), which were notably attenuated by XBJ injection (P < 0.05). Total cell, macrophage, and neutrophils count in BALF and TNF-α and IL-6 levels in blood were significantly increased after DDVP exposure (P < 0.05), which were notably ameliorated by XBJ injection (P < 0.05). TLR4 and NF-κB protein in lung tissue expression after DDVP challenge were markedly increased (P < 0.05), and they were substantially downregulated by XBJ injection (P < 0.05). In addition, blood AChE activity was significantly decreased by DDVP administration (P < 0.05), however, there was no significant improvement after XBJ injection.
CONCLUSION: XBJ injection prevents DDVP poisoning induced lung injury by attenuating the inflammatory response. The protective effect appears to be mediated through downregulation of the TLR4 and NF-κB expression.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30119213     DOI: 10.1016/j.biopha.2018.07.111

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  The HMGB1-RAGE axis induces apoptosis in acute respiratory distress syndrome through PERK/eIF2α/ATF4-mediated endoplasmic reticulum stress.

Authors:  Fei He; Lina Gu; Nan Cai; Jun Ni; Yong Liu; Quan Zhang; Chao Wu
Journal:  Inflamm Res       Date:  2022-07-24       Impact factor: 6.986

2.  Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.

Authors:  Wen-Jiang Zheng; Qian Yan; Yong-Shi Ni; Shao-Feng Zhan; Liu-Liu Yang; Hong-Fa Zhuang; Xiao-Hong Liu; Yong Jiang
Journal:  BioData Min       Date:  2020-10-16       Impact factor: 2.522

Review 3.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

4.  The preventive effect of Chinese herbal preparation Xuebijing against hyperactive inflammation after hepato-pancreato-biliary surgery.

Authors:  Qifan Zhang; Jia Li; Xiaolu Liang; Haorong Xie; Hang Sun; Xinxin Lin; Jie Zhou; Xiangjun He; Bili Zhu
Journal:  Ann Transl Med       Date:  2019-09

5.  Xuebijing attenuates decompression-induced lung injuries.

Authors:  Wen-Tao Meng; Long Qing; Quan Zhou; Wei-Gang Xu
Journal:  Diving Hyperb Med       Date:  2020-12-20       Impact factor: 0.887

6.  Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production.

Authors:  Xin-Tong Wang; Zhen Peng; Ying-Ying An; Ting Shang; Guangxu Xiao; Shuang He; Xi Chen; Han Zhang; Yuefei Wang; Tao Wang; Jun-Hua Zhang; Xiumei Gao; Yan Zhu; Yuxin Feng
Journal:  Front Pharmacol       Date:  2021-04-13       Impact factor: 5.810

Review 7.  Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.

Authors:  Qin Qiu; Yuge Huang; Xiaohua Liu; Fangfang Huang; Xiaoling Li; Liao Cui; Hui Luo; Lianxiang Luo
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

8.  Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.

Authors:  Yansha Song; Xiaocen Wang; Cuicui Chen; Tingting Wei; Ke Lang; Dong Yang; Yuanlin Song
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

9.  Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans-Induced Epithelial Death in the Kidney.

Authors:  Ting Shang; Qilin Yu; Tongtong Ren; Xin-Tong Wang; Hongyan Zhu; Jia-Ming Gao; Guixiang Pan; Xiumei Gao; Yan Zhu; Yuxin Feng; Ming-Chun Li
Journal:  Front Pharmacol       Date:  2020-01-06       Impact factor: 5.810

10.  The efficacy and safety of Xuebijing injection as an adjunctive treatment for acute pancreatitis: Protocol for a systematic review and meta-analysis of randomized controlled trials.

Authors:  Qilin Tang; Lixin Tian; Chao Gao; Kai Zhang; Nan Su; Baohong Liu; Jingbo Zhai; Si Liu; Yan Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.